NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of EPAM Systems, Inc. (NYSE:EPAM), Sibanye Gold Limited (NYSE:SBGL), Fate Therapeutics, Inc. (NASDAQ:FATE), Howard Hughes Corporation (NYSE:HHC), CBL & Associates Properties, Inc. (NYSE:CBL), and Quorum Health Corporation (NYSE:QHC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

EPAM DOWNLOAD: http://Fundamental-Markets.com/register/?so=EPAM
SBGL DOWNLOAD: http://Fundamental-Markets.com/register/?so=SBGL
FATE DOWNLOAD: http://Fundamental-Markets.com/register/?so=FATE
HHC DOWNLOAD: http://Fundamental-Markets.com/register/?so=HHC
CBL DOWNLOAD: http://Fundamental-Markets.com/register/?so=CBL
QHC DOWNLOAD: http://Fundamental-Markets.com/register/?so=QHC

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine EPAM Systems, Inc. (NYSE:EPAM), Sibanye Gold Limited (NYSE:SBGL), Fate Therapeutics, Inc. (NASDAQ:FATE), Howard Hughes Corporation (NYSE:HHC), CBL & Associates Properties, Inc. (NYSE:CBL), and Quorum Health Corporation (NYSE:QHC) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed March 26th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

EPAM SYSTEMS, INC. (EPAM) REPORT OVERVIEW

EPAM's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, EPAM reported revenue of $399.30MM vs $313.53MM (up 27.36%) and basic earnings per share -$0.59 vs $0.49. For the twelve months ended December 31st, 2017 vs December 31st, 2016, EPAM reported revenue of $1,450.45MM vs $1,160.13MM (up 25.02%) and basic earnings per share $1.40 vs $1.97 (down 28.93%). EPAM is expected to report earnings on May 3rd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.51. The estimated EPS forecast for the next fiscal year is $4.14 and is expected to report on February 15th, 2019.

To read the full EPAM Systems, Inc. (EPAM) report, download it here: http://Fundamental-Markets.com/register/?so=EPAM

-----------------------------------------

SIBANYE GOLD LIMITED (SBGL) REPORT OVERVIEW

Sibanye Gold's Recent Financial Performance

For the twelve months ended December 31st, 2017 vs December 31st, 2016, Sibanye Gold reported revenue of $3,449.40MM vs $2,130.62MM (up 61.90%) and basic earnings per share -$0.68 vs $1.07.

To read the full Sibanye Gold Limited (SBGL) report, download it here: http://Fundamental-Markets.com/register/?so=SBGL

-----------------------------------------

FATE THERAPEUTICS, INC. (FATE) REPORT OVERVIEW

Fate Therapeutics' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Fate Therapeutics reported revenue of $1.03MM vs $1.03MM (unchanged) and basic earnings per share -$0.29 vs -$0.20. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Fate Therapeutics reported revenue of $4.11MM vs $4.40MM (down 6.72%) and basic earnings per share -$1.02 vs -$1.05. Fate Therapeutics is expected to report earnings on May 21st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.24. The estimated EPS forecast for the next fiscal year is -$1.03 and is expected to report on March 4th, 2019.

To read the full Fate Therapeutics, Inc. (FATE) report, download it here: http://Fundamental-Markets.com/register/?so=FATE

-----------------------------------------

HOWARD HUGHES CORPORATION (HHC) REPORT OVERVIEW

Howard Hughes' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Howard Hughes reported revenue of $300.98MM vs $279.56MM (up 7.66%) and basic earnings per share $3.60 vs $1.10 (up 227.27%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Howard Hughes reported revenue of $1,100.12MM vs $1,035.01MM (up 6.29%) and basic earnings per share $4.07 vs $5.12 (down 20.51%). Howard Hughes is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.13.

To read the full Howard Hughes Corporation (HHC) report, download it here: http://Fundamental-Markets.com/register/?so=HHC

-----------------------------------------

CBL & ASSOCIATES PROPERTIES, INC. (CBL) REPORT OVERVIEW

CBL & Associates Properties' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, CBL & Associates Properties reported revenue of $235.36MM vs $258.49MM (down 8.95%) and basic earnings per share $0.14 vs $0.34 (down 58.82%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, CBL & Associates Properties reported revenue of $927.25MM vs $1,028.26MM (down 9.82%) and basic earnings per share $0.44 vs $0.75 (down 41.33%). CBL & Associates Properties is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.52. The estimated EPS forecast for the next fiscal year is $1.70 and is expected to report on February 14th, 2019.

To read the full CBL & Associates Properties, Inc. (CBL) report, download it here: http://Fundamental-Markets.com/register/?so=CBL

-----------------------------------------

QUORUM HEALTH CORPORATION (QHC) REPORT OVERVIEW

Quorum Health's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Quorum Health reported revenue of $515.08MM vs $515.24MM (down 0.03%) and basic earnings per share -$0.95 vs -$3.19. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Quorum Health reported revenue of $2,072.17MM vs $2,138.47MM (down 3.10%) and basic earnings per share -$4.06 vs -$12.24. Quorum Health is expected to report earnings on May 21st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.85. The estimated EPS forecast for the next fiscal year is -$0.37 and is expected to report on March 21st, 2019.

To read the full Quorum Health Corporation (QHC) report, download it here: http://Fundamental-Markets.com/register/?so=QHC

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.